Skip to main content
Clinical Trials/NCT03875248
NCT03875248
Unknown
Not Applicable

Arm 1: Optical Blood Pressure Monitoring (OptiBP Mobile App), An Accurate Blood Pressure Measurement Compared to Invasive Blood Pressure Measurement. Arm 2 and Arm 3: Improvement and Validation of the Smartphone Blood Pressure Measurement (OptiBP Mobile App). A Prospective, Method Comparison, Proof of Concept Study in a Swiss Population.

Biospectal2 sites in 1 country350 target enrollmentStarted: March 18, 2019Last updated:
ConditionsBlood Pressure

Overview

Phase
Not Applicable
Sponsor
Biospectal
Enrollment
350
Locations
2
Primary Endpoint
Confirmation of measurement done with the investigational device

Overview

Brief Summary

Validation of an existing algorithm designed to estimate blood pressure based on collected optical signals on patients against two reference methods, which are the arterial catheter (arm 1) and the ausculatory sphygmomanometer (arm 2).

Detailed Description

The purpose of the study is to compare the blood pressure values measured by a mobile application used with a smartphone and the values measured by reference equipments, which are the arterial line and the ausculatory sphygmomanometer .

In the arm 1 of the study, patients scheduled for general anesthesia at the Centre Hospitalier Universitaire Vaudois (CHUV) and at the Hôpitaux Universitaire de Genève (HUG) will be recruited and their pressure will be measured with both mesurement methods. General anesthesia is known to generate significant variations in blood pressure at the time of induction. During the first minutes of anesthesia, the patient's blood pressure will be measured in parallel with the mobile application and with the reference equipment. After the intervention, the values obtained by the two methods will be compared to confirm the reliability of the data obtained with the mobile application.

In the arm 2, patients scheduled for a medical appointment at the hypertension unit of the Centre Hospitalier Universitaire Vaudois (CHUV) will be recruited. Their pressure will be measured with the mobile application and with the reference equipment at various time points. After the intervention, the values obtained by the two methods will be compared to confirm the reliability of the data obtained with the mobile application.

In the arm 3, patients scheduled for a medical appointment at the maternity unit of the Centre Hospitalier Universitaire Vaudois (CHUV) will be recruited. Their pressure will be measured with the mobile application and with the reference equipment at various time points. After the intervention, the values obtained by the two methods will be compared to confirm the reliability of the data obtained with the mobile application.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Informed Consent as documented by signature
  • Men or women older than 18 years old
  • Good understanding of written and oral speaking used at the centre where the study will be carried out
  • American Society of Anesthesiology clinical classification Risk (ASA) Class 1-3
  • Scheduled for a general anesthesia
  • Necessitating an arterial catheters for the anesthesia and surgery.

Exclusion Criteria

  • Patients that cannot sign informed consent
  • Patients in emergency situation, are not legally competent, cannot understand the situation
  • ASA Risk class 4
  • Dyshythmia like bigeminy, trigeminy, isolated Ventricular Premature Beats (VPB), atrial fibrillation
  • Lesion or deficiency on hand, preventing index obstruction of smartphone's camera
  • Known contact dermatitis to nickel/chromium
  • Arm 2, Inclusion Criteria:
  • Informed Consent as documented by signature
  • Men or women older than 18 years old
  • Good understanding of written and oral speaking used at the centre where the study will be carried out

Outcomes

Primary Outcomes

Confirmation of measurement done with the investigational device

Time Frame: First 20 minutes

Arm 3: Comparision of values to non-invasive reference method (ausculatory sphygmomanometer)

Secondary Outcomes

  • Usability assessment(First 20 minutes)
  • Safety of procedure by assessing inconvenience and adverse events(First 20 minutes)

Investigators

Sponsor
Biospectal
Sponsor Class
Industry
Responsible Party
Principal Investigator
Principal Investigator

Patrick Schoettker

Professor, Head of Anaesthesia Unit

Centre Hospitalier Universitaire Vaudois

Study Sites (2)

Loading locations...

Similar Trials